Is There a Future for Moderna Beyond COVID-19?
While Moderna (NASDAQ: MRNA) is famous for its COVID-19 vaccine, the biotech actually has a vast development pipeline for many other mRNA vaccines. This year, all the revenues are going to come from vaccinating people to stop COVID, but over the next decade, the company might have revenues from a variety of vaccines and therapies.
In this video from Motley Fool Live recorded on Feb. 19, Healthcare and Cannabis Bureau Chief Corinne Jurney Cardina and Fool contributor Taylor Carmichael discuss Moderna's platform outside of COVID.
Source Fool.com
